Maynard Um
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Ovid Therapeutics Inc (OVID)
-
-
-
-
-
-
-
Leerink Partners Starts Ovid Therapeutics Inc (OVID) at Outperform
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Ovid Therapeutics Inc (OVID)
-
-
-
-
-
-
-
Ovid Therapeutics Inc (OVID) PT Lowered to $2 at H.C. Wainwright
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Ovid Therapeutics Inc (OVID)
-
-
-
-
-
-
-
Ovid Therapeutics (OVID): eNeuro Publishes Findings on the Anti-Convulsant Properties of OV329 and Its Potential Effectiveness in Treatment-Resistant Seizures
-
-
-
-
-
-
-
Ovid Therapeutics Inc (OVID) PT Lowered to $5 at BTIG
-
448,577 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

